As the world reopened in 2021, investors reacted quickly and FDI levels rose by 18.1% compared to figures from the previous year. Most sectors have witnessed a rise in their number of projects, including the nucleic acid therapeutics sector in the biotech space. "The pandemic exposed the need for global cooperation for public health, and that there’s a lot of money to be made in developing public health solutions," said Global Trade associate Justin Pierce, while speaking with Pharmaceutical Technology.